- Invited speaker presentation
- Open Access
IL-12 superfamily members guiding the function of Rorγt-dependent innate lymphocytes
- Burkhard Becher1
© Becher; licensee BioMed Central Ltd. 2012
Published: 28 November 2012
Most MHC class II expressing Ag-presenting cells (APCs) have the capacity to produce the cytokines IL-12 and IL-23 . Both these heterodimeric pro-inflammatory cytokines share a common subunit (p40) which is covalently linked to p35 to form IL-12 and to p19 to form IL-23. The biology of these two related cytokines is extremely divers. IL-12 is best known for its capacity to polarize TH1 cells and to activate NK and NKT cells. IL-12 is thus primarily involved in the initiation of cellular immune responses agains intracellular pathogens. The biology of IL-23 is much less understood, but it becomes increasingly clear that IL-23 can activate innate lymphocytes including a subclass of γδ T cells  and Rorγt-dependent innate lymphocytes (ILCs) . IL-23 is further critical for the development of self-reactive pathogenic αβ helper T cells in various models of autoimmune diseases .
In the context of anti-tumor immunity we discovered that IL-23 plays only a minor role in the development of anti-tumor responses. In fact, we found IL-23 to have primarily tumor-supportive properties. In contrast, IL-12 has clearly a potent tumor-suppressive properties. Surprisingly, we identified a Rorγt-dependent IL-12R bearing ILC homing into the microenvironment of skin tumors . These ILCs upon sensing IL-12 are able to mount a potent innate response in the tumor-microenvironment, leading to alterations in tumor microvessels and the formation of a pro-inflammatory myeloid cell response. Taken together, our initial understanding of IL-12 and IL-23 biology was restricted to adaptive T cells. The impact of these cytokines on γδ T cells and ILCs is only now being discovered.
- Gutcher I, Becher B: APC-derived cytokines and T cell polarization in autoimmune inflammation. J.Cin. Invest. 2007, 117: 1119-1127. 10.1172/JCI31720.View ArticleGoogle Scholar
- Pantelyushin S, Haak S, Ingold B, Kulig P, Heppner FL, Navarini AA, Becher B: Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J.Cin. Invest. 2012, 122: 2252-2256. 10.1172/JCI61862.View ArticleGoogle Scholar
- Vonarbourg C, Mortha A, Bui VL, Hernandez PP, Kiss EA, Hoyler T, Flach M: Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. Immunity. 2010, 33: 736-751. 10.1016/j.immuni.2010.10.017.PubMed CentralView ArticlePubMedGoogle Scholar
- Croxford AL, Mair F, Becher B: IL-23: One cytokine in control of autoimmunity. Eur. J. Immunol. 2012, 42: 2263-2273. 10.1002/eji.201242598.View ArticlePubMedGoogle Scholar
- Eisenring M, vom Berg J, Kristiansen G, Saller E, Becher B: IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46. Nat Immunol. 2010, 11: 1030-1038. 10.1038/ni.1947.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.